Literature DB >> 17623733

Validity of performance scales for disability assessment in multiple sclerosis.

R A Marrie1, M Goldman.   

Abstract

Researchers increasingly use self-reported health status assessments, but these require validation. Performance Scales (PS) is a self-report measure for multiple sclerosis (MS)-associated disability, assessing mobility, bowel/bladder, fatigue, sensory, vision, cognition, spasticity and hand function. The criterion validity of the total PS score was established using the Expanded Disability Status Scale (EDSS), but the construct and criterion validity of the individual subscales have not been established. We assessed the criterion and construct validity of the PS subscales. Forty-four patients with MS completed PS, and these criterion measurements: neurological examination (EDSS), the Multiple Sclerosis Functional Composite (MSFC), contrast acuity testing, and the Multiple Sclerosis Quality of Life Inventory. We assessed criterion and construct validity with Spearman rank correlations between PS subscales and the other measurements. PS correlated with the MSFC (r=-0.58, P<0.0001). The mobility, hand, vision, fatigue and bladder subscales correlated with their criterion measures (r=0.59-0.77, P<0.0001). The sensory subscale correlated weakly with the sensory functional system score (r=0.39, P=0.01 ), and the cognitive subscale did not correlate with the PASAT (r=-0.17, P=0.26). This study supports the criterion and construct validity of PS overall, and its mobility, hand, vision, fatigue, and bladder subscales. Further assessment of the cognitive, sensory and spasticity subscales is needed.

Entities:  

Mesh:

Year:  2007        PMID: 17623733     DOI: 10.1177/1352458507078388

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  86 in total

1.  Comparing two conditions of administering the six-minute walk test in people with multiple sclerosis.

Authors:  Brian M Sandroff; Lara A Pilutti; Deirdre Dlugonski; Yvonne C Learmonth; John H Pula; Robert W Motl
Journal:  Int J MS Care       Date:  2014

2.  Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).

Authors:  Tjalf Ziemssen; Glenn Phillips; Ruchit Shah; Adam Mathias; Catherine Foley; Cheryl Coon; Rohini Sen; Andrew Lee; Sonalee Agarwal
Journal:  J Neurol       Date:  2016-07-08       Impact factor: 4.849

3.  Goals set after completing a teleconference-delivered program for managing multiple sclerosis fatigue.

Authors:  Miho Asano; Katharine Preissner; Rose Duffy; Maggie Meixell; Marcia Finlayson
Journal:  Am J Occup Ther       Date:  2015 May-Jun

4.  A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.

Authors:  Sarah Acaster; Rodolphe Perard; Deven Chauhan; Andrew J Lloyd
Journal:  BMC Health Serv Res       Date:  2013-09-09       Impact factor: 2.655

5.  Depressive Symptoms in Bariatric Surgery Patients with Multiple Sclerosis.

Authors:  Carolyn J Fisher; Leslie J Heinberg; Brittany Lapin; Ali Aminian; Amy B Sullivan
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

6.  Health insurance affects the use of disease-modifying therapy in multiple sclerosis.

Authors:  Guoqiao Wang; Ruth Ann Marrie; Amber R Salter; Robert Fox; Stacey S Cofield; Tuula Tyry; Gary R Cutter
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

7.  Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.

Authors:  R A Marrie; R Rudick; R Horwitz; G Cutter; T Tyry; D Campagnolo; T Vollmer
Journal:  Neurology       Date:  2010-03-30       Impact factor: 9.910

8.  Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.

Authors:  Myla D Goldman; Robert W Motl; John Scagnelli; John H Pula; Jacob J Sosnoff; Diego Cadavid
Journal:  Neurology       Date:  2013-10-30       Impact factor: 9.910

9.  A tutorial on structural equation modeling for analysis of overlapping symptoms in co-occurring conditions using MPlus.

Authors:  Douglas D Gunzler; Nathan Morris
Journal:  Stat Med       Date:  2015-06-04       Impact factor: 2.373

10.  Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.

Authors:  Brian M Sandroff; Rachel E Klaren; Lara A Pilutti; Deirdre Dlugonski; Ralph H B Benedict; Robert W Motl
Journal:  J Neurol       Date:  2013-12-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.